Protective Immunity Against Herpesvirus Infections

针对疱疹病毒感染的保护性免疫

• 批准号: 8260368
• 负责人: Ann Arvin
• 金额: $ 24.31万
• 依托单位: STANFORD UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-04-01 至 2013-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8260368
• 关键词: Adoptive Transfer; Allogenic; Animals; Antigens; Antiviral Agents; Appearance; Biological Assay; Bone Marrow Transplantation; CD8B1 gene; Cell Therapy; Cell Transplantation; Cells; Clinical; Clinical Management; Clinical Research; Cytomegalovirus; Disease; Evaluation; Firefly Luciferases; Flow Cytometry; Frequencies; Goals; Harvest; Hematopoietic; Herpesviridae; Herpesviridae Infections; Herpesvirus Type 3; Human; Immune; Immune response; Immunity; Immunohistochemistry; Immunotherapy; Infection; Infection Control; Infusion procedures; Interferons; Interleukin-15; Intervention; Intraperitoneal Injections; Intravenous infusion procedures; Killer Cells; Kinetics; Lymphocyte; Measures; Methods; Modality; Modeling; Monitor; Morbidity - disease rate; Mus; NF-kappa B; Natural Immunity; Natural Killer Cells; Neuroglia; Neurons; Neurotropism; Nuclear; Patients; Pattern; Peripheral Blood Mononuclear Cell; Phenotype; Population; Production; Prophylactic treatment; Prospective Studies; Proteins; Recombinant Cytokines; Recombinant Interferon; Recovery; Regimen; Regression Analysis; Regulation; Relapse; Relative (related person); Reporter; SCID Mice; Saline; Sensory Ganglia; Signal Pathway; Skin; Spinal Ganglia; Structure; System; T-Lymphocyte; Testing; Tissues; Up-Regulation; Vaccines; Viremia; Virus; Virus Diseases; Virus Replication; Xenograft procedure; adaptive immunity; conditioning; cytokine; graft vs host disease; improved; in vivo; insight; killer inhibitory receptor; leukemia/lymphoma; mouse model; prospective; receptor; reconstitution; research study; response; restoration; rituximab